| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K09587429 |
| PharmacoGx | BRD-K09587429 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | ZW10 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ZSCAN25 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | ZRSR1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ZNRD1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | ZNHIT1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | ZNF853 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | ZNF812P | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
